论文信息 - Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer - 字舞流文

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

D. Mandelker | K. Cadoo | R. Rampal | Anastasia Navitski | R. O’Cearbhaill | Ying Liu | C. Friedman | Duaa H Al-Rawi | M. Rubinstein